Elite in Pemphigus and Fogo Selvagem

Valeria Aoki

Sao Paulo, SP, BR 
Elite in Pemphigus and Fogo Selvagem
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Valeria Aoki practices in Sao Paulo, Brazil. Ms. Aoki is rated as an Elite expert by MediFind in the treatment of Pemphigus and Fogo Selvagem. Her top areas of expertise are Pemphigus and Fogo Selvagem, Pemphigus, Pemphigus Foliaceus, and Pemphigus Vulgaris.

Her clinical research consists of co-authoring 136 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 15 articles in the study of Pemphigus and Fogo Selvagem.

Gender
Female

Locations

Sao Paulo, SP, Brazil
Other Locations
Av. Dr. Eneas De Carvalho Aguiar, 255, 3o. Andar ICHC, Sala, Sao Paulo SP, 3016, Cerqueira Cesar, SP 05403002, Brazil
Paulo, MA, Brazil
Av. Dr. Enéas Carvalho De Aguiar 500, Vila Carvalho, SP 05403000, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drugs: Baricitinib, Corticosteroid
Study Phase: Phase 3

136 Total Publications

Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2).
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2).
Journal: Dermatology and therapy
Published: June 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Aoki's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile